Você esta aqui:Home > Therapeutics (antigo) > Cannabis Use by Persons Living with HIV/AIDS: Patterns and Prevalence of Use

J Cannabis Ther 2003(2):03-15

Cannabis in HIV/AIDS

Cannabis Use by Persons Living with HIV/AIDS: Patterns and Prevalence of Use

Author
M.A. Ware, S. Rueda, J. Singer, D. Kilby

Abstract
This study was undertaken to determine the prevalence of use, reasons for use, amounts and methods used, and perceived effectiveness of cannabis and dronabinol among persons living with HIV/AIDS in Canada.

Cross-sectional anonymous self-administered questionnaire study. Four hundred patients were consecutively recruited from 3 primary care HIV clinics in Toronto, Ottawa and Montreal, and 50 questionnaires were distributed to PHAs (persons having AIDS) at one "cannabis compassion club."

Responses were received from 160 clinic patients and 19 compassion club patients (40% response rate). Of 160 PHAs attending the HIV clinics, 59 patients (37.3%, 95% CI 29.5-45.1%) reported current use of cannabis.

Of 19 compassion club clients, all reported current use of cannabis. Cannabis was most commonly used for stress relief and loss of appetite in both populations, in addition to relief of stress and nausea. Side effects included "high" and dry mouth. Dronabinol and cannabis were also reported to relieve adverse effects of antiretroviral therapy. Dronabinol is less widely used, cannabis being preferred.

Cannabis is commonly used among PHAs for a wide range of symptom relief. Clinical trials using standardized material are required to assess the magnitude of the effects of cannabis, to explore the role of the placebo effect, and to define dose exposures for risk-benefit assessment.


Keywords
Cannabis, marijuana, epidemiology, clinical trials, antiretroviral therapy, knowledge/attitude/practice studies, wasting/nutrition

PDF do texto completo ]

Eventos Online Grátis 2020

Pode encontrar todas as informações aqui.

A IACM está a realizar uma série de webinars gratuitos e uma reunião on-line de aniversário gratuita de Outubro a Dezembro de 2020.

Todos os webinars serão realizados em inglês com legendas em alemão, francês, espanhol, e português. Todos os webinars estarão disponíveis online até Março de 2021.

A reunião online de aniversário para celebrar o 20º aniversário da IACM e para honrar o 90º aniversário de Raphael Mechoulam será uma sessão ao vivo apenas no dia 5 de Novembro de 2020.

Os oradores da série de webinários são Donald I. Abrams, Bonni Goldstein, Franjo Grotenhermen, Manuel Guzmán, Raphael Mechoulam, Kirsten Müller-Vahl, Roger Pertwee, Daniele Piomelli, e Ethan Russo.

Pode encontrar todas as informações aqui.

Conferência 2021

A 12ª Conferência da IACM sobre Canabinoides em Medicina será realizada em Basileia, Suíça, de 14 a 16 de Outubro de 2021.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.